Mount Sinai Heart will host its innovative and prestigious 17th Annual 2014 Live Symposium of Complex Coronary, Valvular, and Vascular Cases June 10-13 at The Mount Sinai Hospital.
The special four-day Symposium will feature more than 29 "live" broadcasts of complex cardiovascular interventional procedures transmitted from inside Mount Sinai Heart's leading Cardiac Catheterization Laboratory. Also, the Symposium will include leading expert presentations and panel discussions by more than 100 guest faculty from around the nation and the world addressing the latest advances and approaches to managing patients with simple and complex coronary, valvular, and vascular diseases.
"Our fields of interventional cardiology, structural heart disease, and endovascular intervention continue to evolve at a high-speed pace each year with new emerging clinical trial results, therapies, and technology," says Samin Sharma, MD, Director of Clinical & Interventional Cardiology at Mount Sinai Heart. "This is exactly why the world's leading interventionalists gather each year at Mount Sinai to educate and update each other and our fellow colleagues with the common mission of improving evidence-based medical care, procedural appropriateness, efficiency, and most of all patient safety for our patients with coronary, valvular, and peripheral vascular diseases."
More than 1,000 interventional cardiac specialists, interventional radiologists, vascular surgeons, cardiology fellows, nurses, technicians and other allied healthcare professionals working in cardiac catheterization and vascular laboratories around the globe are registered to attend.
This year's Symposium will kick-off with one-day dedicated to its innovative Nurse/Technologist Symposium (June 10), followed by three Symposium days devoted to exploring the advances and emerging areas of endovascular intervention (June 11), complex coronary intervention (June 12), and structural heart disease (June 13).
The event will have a special focus on the advances in managing and treating cardiovascular blockages that are severely calcified, have bifurcation, or are totally occluded. Also, the agenda will explore novel interventional devices and techniques such as transcatheter aortic-valve replacement (TAVR), mitral valve repair, revascularization choice of PCI, CABG, or hybrid revascularization for patients with advanced coronary artery disease.
Dr. Samin Sharma, along with Annapoorna S. Kini, MD, the Director of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital, will host the large event as Directors of the Coronary and Structural Heart Symposiums. They are joined by other leading cardiovascular experts Prakash Krishnan, MD, Director of Endovascular Intervention in the Cardiac Catheterization Lab and Peter L. Faries, MD, Chief of Vascular Surgery at The Mount Sinai Hospital who are both the Directors of the Endovascular Symposium. Also, the Directors of the special Nurse/Technologist Symposium are Beth Oliver, DNP, RN, Vice President of Cardiac Services for the Mount Sinai Health System and Antonietta Tolentina, MSN, ANP-C.
The goal of Mount Sinai Heart's innovative Symposium, launched in 1998, is to continuously drive innovation in the field of interventional cardiovascular medicine and to help others in the field achieve safer procedural outcomes and appropriately select the best procedure for each of their patients. For 16 consecutive years, the Cardiac Catheterization Laboratory of Mount Sinai Heart has received the highest "two-star" safety rating by New York State's Department of Health, while performing the highest volume of percutaneous coronary interventions (PCI), and complex cases.
"This year's Symposium will enhance your overall knowledge and understanding of the latest interventional techniques and available technology to better manage your patients with various cardiac disease states and complex, challenging conditions," says Dr. Annapoorna Kini, Director of the Cardiac Catheterization Lab at The Mount Sinai Hospital. "Upon completion of this program, attendees will be able to better assess complex cases, appropriateness of techniques, imaging technology, and plan for the best interventional strategy possible for your patients armed with the latest evidence-based data we will share at the Symposium."
To learn more about the 17th Annual 2014 Live Symposium of Complex Coronary, Valvular, and Vascular Cases, please visit: www.cccsymposium.org
New nasal spray form of bumetanide shows promise for heart failure treatment